Alogliptin 25Â mg treated vs control | |||
---|---|---|---|
Lipid profile | Std. Mean Difference (95% CI) | I2 | Number of included studies |
Change in total cholesterol | −0.16 [−0.46, 0.15] | 76% | |
Change in LDL-cholesterol | −0.05 [−0.27, 0.16] | 53% | |
Change in HDL-cholesterol | −0.17 [−0.32, -0.02] | 0% | |
Change in triglycerides | −0.14 [−0.33, 0.05] | 39% | |
Alogliptin 12.5Â mg treated vs control | |||
Change in total cholestrol | −0.13 [−0.37, 0.10] | 60% | |
Change in LDL-cholestrol | −0.10 [−0.25, 0.05] | 0% | |
Change in HDL-cholesterol | −0.13 [−0.28, 0.02] | 0% | |
Change in triglycerides | −0.06 [−0.29, 0.17] | 58% |